CLOSE X

SUDEEP PHARMA LTD.

NSE : SUDEEPPHRMBSE : 544619ISIN CODE : INE0QPI01025Industry : Pharmaceuticals & DrugsHouse : Private
BSE1198.8554.55 (+4.77 %)
PREV CLOSE ( ) 1144.30
OPEN PRICE ( ) 1108.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 30375
TODAY'S LOW / HIGH ( )1108.20 1201.50
52 WK LOW / HIGH ( )524.95 1376
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 21-12 1989
Management Info
- Chairman Sujit Jaysukh Bhayani - Managing Director
Registered Office

Address 129/1/ A, G. I. D. C. Estate,Nandesari, ,
Vadodara,
Gujarat-391340

Phone 0265 2840656 / 7624095107

Email mail@sudeepgroup.com

Website www.sudeepgroup.com

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
16Sep Sudeep Pharma informs about analyst meet
Sudeep Pharma has informed that the officials of the Company will be att..
05Aug Sudeep Pharma submits newspaper publ
With reference to its Letter dated 4th August 2026 vide which it has sub..
25Jun Sudeep Pharma informs about closure of
Pursuant to the Code of Conduct on Prevention of Insider Trading of the..
22May Sudeep Pharma informs about press rele
Sudeep Pharma has informed that it submitted the copies of the extract o..
10Apr Sudeep Pharma informs about certificate
Sudeep Pharma has informed that it enclosed certificate under Regulation..
Financials
Rs. in Millions
QTR Jun 26 ANNUAL 26
Net Profit338.31075.8
Gross Profit 454.09 1450.96
Operating Profit 489.951582.72
Net Sales 1056.833385.05
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 27223.20 (0.96%)
M.Cap ( in Cr)57847.40
NGL Fine-Chem (BSE)
 2846.65 (4.25%)
M.Cap ( in Cr)1758.67
Haleos Labs (BSE)
 1533.00 (4.44%)
M.Cap ( in Cr)463.47
Mankind Pharma (BSE)
 2479.40 (2.04%)
M.Cap ( in Cr)102410.40
Astrazeneca Pharma (BSE)
 6712.15 (0.72%)
M.Cap ( in Cr)16780.38
Shareholding Pattern
PROMOTERS 76.15%
NON-INSTITUTION 6.39%
MUTUAL FUNDS/UTI 5.47%
FI/BANKS/INSURANCE 1.39%
GOVERNMENT 0%
FII 0%
Mf Holdings
Scheme NameHold(%)
No Data Found
Advisory for Investors Complaints Data August 2026 Broking Complaints Data August 2026 DP

Filing of complaints through SEBI’s online portal ‘SCORES’ and ‘SMARTODR portal’ - Easy & quick

  • > Register On SCORES / SMARTODR Portal
  • > Mandatory Details For filling Complaints on SCORES: (Name, PAN, Address, Mobile Number, Email ID)
  • > Benefits:
    • Effective communication
    • Speedy Redressal of Grievance / Dispute
  • http://scores.sebi.gov.in
  • https://smartodr.in/login
Process Flow of Complaint Redressal Mechanism

Details of Client Bank account of Badjate Stock & Shares Private Limited:

  • 1)Client Bank account Number : 01020340001341
  • 2)Name of Bank Account :
    BADJATE STOCK AND SHARES PRIVATE LIMITED - USCNB Account
  • 3)IFSC : HDFC0000102
  • 4)BRANCH : Shankar Nagar / Dharampeth Extn Nagpur
  • 5)MICR – 440240002
  • 6)Verified UPI ID for receiving Payments: badjate.rzp1.brk@validhdfc
  • 7)Click here for QR Code

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html We believe that an educated investor is a protected investor !!!

ATTENTION INVESTORS| KYC | IPO | CLIENT BANK A/C| DIRECT ON-BOARDING FOR PMS SERVICES

© Badjate Group 2018

Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.